Low-molecular-weight heparin for prevention of placenta-mediated pregnancy complications: Protocol for a systematic review and individual patient data meta-analysis (AFFIRM)

Systematic Reviews

Volumn 3, Issue 1, 2015, Pages

  Rodger, Marc A ^a   Langlois, Nicole J ^a   de Vries, Johanna I P ^b   Rey, Évelyne ^c   Gris, Jean Christophe ^d   Martinelli, Ida ^e   Schleussner, Ekkehard ^f   Ramsay, Timothy ^a   Mallick, Ranjeeta ^a   Skidmore, Becky ^g   Middeldorp, Saskia ^h   Bates, Shannon ⁱ   Petroff, David ^j   Bezemer, Dick ^b   van Hoorn, Marion E ^b   Abheiden, Carolien N H ^b   Perna, Annalisa ^k   de Jong, Paulien ^l   Kaaja, Risto ^m  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MONTREAL   (Canada)

^d CHU Ste Justine 3175 chemin de la Côte Sainte Catherine ^*  (France)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^f JENA UNIVERSITY HOSPITAL   (Germany)

^g Independent information specialist   (Canada)

^h ACADEMIC MEDICAL CENTER   (Netherlands)

ⁱ MCMASTER UNIVERSITY   (Canada)

^j UNIVERSITY OF LEIPZIG   (Germany)

^k MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^l UNIVERSITY OF AMSTERDAM   (Netherlands)

^m UNIVERSITY OF TURKU   (Finland)

more..

Author keywords

Individual patient data meta analysis; Low molecular weight heparin; Meta analysis; Placenta mediated pregnancy complications; Placental abruption; Pre eclampsia; Pregnancy; Pregnancy loss; Small for gestational age; Systematic review

Indexed keywords

ACETYLSALICYLIC ACID; DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ALLERGIC REACTION; ANAPHYLAXIS; ANTEPARTUM HEMORRHAGE; ARTICLE; DEEP VEIN THROMBOSIS; FETUS DEATH; FETUS WASTAGE; HELLP SYNDROME; HUMAN; KNOWLEDGE BASE; LUNG EMBOLISM; META ANALYSIS; OUTCOME ASSESSMENT; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; SMALL FOR DATE INFANT; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; FEMALE; INFORMATION RETRIEVAL; LITERATURE; PLACENTA DISEASES; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATIONS;

FEMALE; GUIDELINES AS TOPIC; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INFORMATION STORAGE AND RETRIEVAL; PLACENTA DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REVIEW LITERATURE AS TOPIC;

EID: 84923057062     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/2046-4053-3-69     Document Type: Article

References (43)

1. Rodger MA, Carrier M, Le Gal G, Martinelli I, Perna A, Rey E, De Vries JI, Gris JC. Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications. Blood 2014, 123:822-828. 10.1182/blood-2013-01-478958, 24357725.
2. van der Molen EF, Verbruggen B, Novakova I, Eskes TK, Monnens LA, Blom HJ. Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy. BJOG 2000, 107:785-791. 10.1111/j.1471-0528.2000.tb13341.x, 10847236.
3. Weiner Z, Younis JS, Blumenfeld Z, Shalev E. Assessment of uterine placental circulation in thrombophilic women. Semin Thromb Hemost 2003, 29:213-218. 10.1055/s-2003-38837, 12709925.
4. Arias F, Romero R, Joist H, Kraus FT. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta. J Matern Fetal Med 1998, 7:277-286.
5. Sood R, Kalloway S, Mast AE, Hillard CJ, Weiler H. Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells. Blood 2006, 107:3173-3180. 10.1182/blood-2005-10-4111, 1895751, 16380449.
6. Steegers EA, Von DP, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010, 376:631-644. 10.1016/S0140-6736(10)60279-6, 20598363.
7. Berg CJ, Atrash HK, Koonin LM, Tucker M. Pregnancy-related mortality in the United States, 1987-1990. Obstet Gynecol 1996, 88:161-167. 10.1016/0029-7844(96)00135-4, 8692494.
8. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006, 367:1066-1074. 10.1016/S0140-6736(06)68397-9, 16581405.
9. Department of Health WO, Scottish Department of Health Why mothers die. Report on confidential enquiries into maternal deaths in the United Kingdom 1994-1996 1998, London: Her Majesty's Stationary Office, Department of Health WO, Scottish Department of Health.
10. Atrash HK, Koonin LM, Lawson HW, Franks AL, Smith JC. Maternal mortality in the United States, 1979-1986. Obstet Gynecol 1990, 76:1055-1060.
11. Rusen ID, Liston R, Wen SW, Bartholomew S. Special Report on Maternal Mortality and Severe Morbidity in Canada. Enhanced Surveillance. The Path to Prevention 2004, Canada: Minister of Public Works and Government Services.
12. Strauss RS. Adult functional outcome of those born small for gestational age: twenty-six-year follow-up of the 1970 British Birth Cohort. JAMA 2000, 283:625-632. 10.1001/jama.283.5.625, 10665702.
13. Strauss RS, Dietz WH. Effects of intrauterine growth retardation in premature infants on early childhood growth. J Pediatr 1997, 130:95-102. 10.1016/S0022-3476(97)70316-0, 9003857.
14. Strauss RS, Dietz WH. Growth and development of term children born with low birth weight: effects of genetic and environmental factors. J Pediatr 1998, 133:67-72. 10.1016/S0022-3476(98)70180-5, 9672513.
15. Van Rijn BB, Hoeks LB, Bots ML, Franx A, Bruinse HW. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol 2006, 195:723-728. 10.1016/j.ajog.2006.06.044, 16949403.
16. Sibai BM, Mercer B, Sarinoglu C. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol 1991, 165:1408-1412. 10.1016/S0002-9378(12)90773-5, 1957870.
17. Hnat MD, Sibai BM, Caritis S, Hauth J, Lindheimer MD, MacPherson C, VanDorsten JP, Landon M, Miodovnik M, Paul R, Meis P, Thurnau G, Dombrowski M. Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. Am J Obstet Gynecol 2002, 186:422-426. 10.1067/mob.2002.120280, 11904601.
18. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007, 369:1791-1798. 10.1016/S0140-6736(07)60712-0, 17512048.
19. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguere Y. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010, 116:402-414. 10.1097/AOG.0b013e3181e9322a, 20664402.
20. De Vries JIP, Van Pampus MG, Hague WM, Bezemer PD, Joosten JH. Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT. J Thromb Haemost 2012, 10:64-72. 10.1111/j.1538-7836.2011.04553.x, 22118560.
21. Gris JC, Chauleur C, Molinari N, Mares P, Fabbro-Peray P, Quere I, Lefrant JY, Haddad B, Dauzat M. Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomised controlled NOH-PE trial. Thromb Haemost 2011, 106:1053-1061. 10.1160/TH11-05-0340, 21946915.
22. Mello G, Parretti E, Fatini C, Riviello C, Gensini F, Marchionni M, Scarselli GF, Gensini GF, Abbate R. Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension 2005, 45:86-91. 10.1161/01.HYP.0000149950.05182.a3, 15557391.
23. Rey E, Garneau P, David M, Gauthier R, Leduc L, Michon N, Morin F, Demers C, Kahn SR, Magee LA, Rodger M. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. J Thromb Haemost 2009, 7:58-64. 10.1111/j.1538-7836.2008.03230.x, 19036070.
24. Gris JC, Chauleur C, Faillie JL, Baer G, Mares P, Fabbro-Peray P, Quere I, Lefrant JY, Haddad B, Dauzat M. Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae. The pilot randomised controlled NOH-AP trial. Thromb Haemost 2010, 104:771-779. 10.1160/TH10-03-0167, 20694277.
25. Martinelli I, Ruggenenti P, Cetin I, Pardi G, Perna A, Vergani P, Acaia B, Facchinetti F, La Sala GB, Bozzo M, Rampello S, Marozio L, Diadei O, Gherardi G, Carminati S, Remuzzi G, Mannucci PM. Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial. Blood 2012, 119:3269-3275. 10.1182/blood-2011-11-391383, 3321853, 22289887.
26. Huhle G, Geberth M, Hoffmann U, Heene DL, Harenberg J. Management of heparin-associated thrombocytopenia in pregnancy with subcutaneous r-hirudin. Gynecol Obstet Invest 2000, 49:67-69. 10.1159/000010216, 10629377.
27. Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005, 106:401-407. 10.1182/blood-2005-02-0626, 15811953.
28. Bank I, Libourel EJ, Middeldorp S, van der Meer J, Buller HR. High rate of skin complications due to low-molecular-weight heparins in pregnant women. J Thromb Haemost 2003, 1:859-861. 10.1046/j.1538-7836.2003.t01-7-00115.x, 12871432.
29. Rodger MA. Thrombophilia and placenta-mediated pregnancy complications: from the bench to bedside to policy. Thromb Res 2008, 123:S96-S100.
30. Rodger MA, Kahn SR, Cranney A, Hodsman A, Kovacs MJ, Clement AM, Lazo-Langner A, Hague WM. Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial. J Thromb Haemost 2007, 5:1600-1606. 10.1111/j.1538-7836.2007.02634.x, 17663731.
31. Sud S, Douketis J. ACP Journal Club. The devil is in the details... or not? A primer on individual patient data meta-analysis. Ann Intern Med 2009, 151:JC1-JC3.
32. Clarke MJ. Individual patient data meta-analyses. Best Pract Res Clin Obstet Gynaecol 2005, 19:47-55. 10.1016/j.bpobgyn.2004.10.011, 15749065.
33. Lambert PC, Sutton AJ, Abrams KR, Jones DR. A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. J ClinEpidemiol 2002, 55:86-94.
34. Sampson M, McGowan J, Cogo E, Grimshaw J, Moher D, Lefebvre C. An evidence-based practice guideline for the peer review of electronic search strategies. J Clin Epidemiol 2009, 62:944-952. 10.1016/j.jclinepi.2008.10.012, 19230612.
35. Schleussner E, Kamin G, Seeliger G, Rogenhofer N, Toth B., for the ETHIG Investigator Group Low-molecular-weight heparin in recurrent pregnancy loss - Results of the ETHIG II study [abstract]. Thromb Res 2013, 131:S73. for the ETHIG Investigator Group.
36. Giancotti A, La TR, Spagnuolo A, D'Ambrosio V, Cerekja A, Piazze J, Chistolini A. Efficacy of three different antithrombotic regimens on pregnancy outcome in pregnant women affected by recurrent pregnancy loss. J Matern Fetal Neonatal Med 2012, 25:1191-1194. 10.3109/14767058.2011.600366, 21988715.
37. Salman SA, Shaaban OM, Zahran KM, Fathalla MM, Anan MA. Low molecular weight heaprin (LMWH) for treatment of recurrent miscarriage negatively tested for antiphospholipid antibodies: a randomized controlled trial [abstract]. Fertil Steril 2012, 98:S191.
38. Visser J, Ulander VM, Helmerhorst FM, Lampinen K, Morin-Papunen L, Bloemenkamp KW, Kaaja RJ. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial. Thromb Haemost 2011, 105:295-301.
39. Clark P, Walker ID, Langhorne P, Crichton L, Thomson A, Greaves M, Whyte S, Greer IA. SPIN: the Scottish Pregnancy Intervention Study: a multicentrerandomised controlled trial of low molecular weight heparin and low dose aspirin in women with recurrent miscarriage. Blood 2010, 115:4162-4167. 10.1182/blood-2010-01-267252, 20237316.
40. Kaandorp SP, Goddijn M, van der Post JA, Hutten BA, Verhoeve HR, Hamulyak K, Mol BW, Folkeringa N, Nahuis M, Papatsonis DN, Papatsonis DN, Buller HR, van der Veen F, Middeldorp S. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 2010, 362:1586-1596. 10.1056/NEJMoa1000641, 20335572.
41. Laskin CA, Spitzer KA, Clark CA, Crowther MR, Ginsberg JS, Hawker GA, Kingdom JC, Barrett J, Gent M. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. J Rheumatol 2009, 36:279-287. 10.3899/jrheum.080763, 19208560.
42. Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005, 3:692-694. 10.1111/j.1538-7836.2005.01204.x, 15842354.
43. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] 2011, The Cochrane Collaboration, [http://www.cochrane-handbook.org].